Trials / Recruiting
RecruitingNCT06841848
Fundus Camera Module for Early Detection of Alzheimer's Disease
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (estimated)
- Sponsor
- I.R.C.C.S. Fondazione Santa Lucia · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Accepted
Summary
Alzheimer's Disease (AD) affects tens of millions of people just in Europe. It is typically detected in its late stage when irreversible damage has already occurred, and current treatments are mostly conservative or palliative. Here we developed a device performing high-resolution multispectral imaging of the eye fundus to detect AD in its early stage. After clinical testing, the proposed device has a high potential to become a method for routine population screening, as it is non-invasive and affordable. The possibility of AD detection in an early stage is crucial for developing a new pharmaceutical treatment that would dramatically improve the lives of millions and save the expenses connected to lifelong healthcare assistance to people with AD in later stages.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Fundoscopic Exam | visualization of the retina using an ophthalmoscope |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2025-12-01
- Completion
- 2026-03-01
- First posted
- 2025-02-24
- Last updated
- 2025-02-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT06841848. Inclusion in this directory is not an endorsement.